Deadline: September 7, 2016
GSK and Save the Children invites nominations for the Healthcare Innovation Award. The award seeks innovations focused on providing healthcare solutions to children under-five, working to reduce child mortality rates within developing countries.
For the Healthcare Innovation Award’s fourth year, special attention will be given to innovations that focus on reaching the hardest to reach children. Extraordinary progress has been made in recent years to reduce the number of children dying before their fifth birthday. Despite this progress, more than five million children still die each year before their fifth birthday, and millions of children are being left behind because of their gender, poverty, or ethnic identity; because they live in remote areas or urban slums; or because they are caught up in conflicts. The HIA this year welcomes ideas for ways in which these children can be reached.
Eligible nominations must
- present innovations being developed or implemented by organisations in countries classified as ‘low’, ‘lower-middle’, through to ‘upper-middle’ income by the World Bank. See the World Bank classifications here.
- Describe an innovative approach or process applied to under-5 child survival that can demonstrate impact within an eligible country.
- Provide proven and successful results in the two years preceding the nomination.
- Be an organisation (public, private, or non-profit), academic/research institution, or healthcare facility.
***Nominees may not be individuals or national government bodies. However, institutions funded by governments may be nominees (such as universities, think-tanks, and QUANGOs).
- More than one eligible organisation can be jointly nominated, if the eligible innovation is a joint project.
- More than one eligible innovation can be nominated from one eligible organisation.
- A separate form should be submitted for each nominee.
- You may nominate your own organisation or an organisation with which you have no affiliation, but you must inform the organisation that it has been nominated, secure their consent to participate, and provide contact details for that organisation.
- Employees of the Save the Children and GSK, any of their group companies, and any other person directly connected with the HIAs or the Awards are excluded from being a Nominee. Employees of GSK and Save the Children are excluded from being Nominators.
- Innovation in child survival and well-being can (and must) take many shapes and forms. The scope of this Award is therefore purposefully broad, and seeks ideas—big or small—that are developed, discovered, invented and/or implemented in developing countries.
- Examples include—but are not limited to—the following: an innovative idea, care approach, tool, technique, process or delivery mechanism that focuses on any aspect of child-health and health system strengthening, including science, health systems, nutrition, research, education or partnerships.
- Furthermore, to ensure that no effective innovation is missed, this Award will also consider innovations in new business models or operational research with plausible pathways to future innovation.
- Innovations will be considered for an Award if they are “new” ideas, or if they represent an adaptation of an existing idea for a new context or environment.
- cash donation from a USD$1 million Award fund that has been made available by GSK
- Promotion through public award announcements and international media coverage
- A ‘Roundtable’ event in their local community that will convene interested and relevant stakeholders from the public, private and non-profit sectors to provide a support network that can help improve and grow the innovation
- Potential additional support may include volunteer and/or technical assistance from GSK and Save the Children staff and country offices
How to Apply
In order to complete the HIA award application, you will need to register/create an account via Innocentive.
For more information, visit GSK & Save the Children Healthcare Innovation Award